M. S. Anwer

1.2k total citations
58 papers, 1.0k citations indexed

About

M. S. Anwer is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, M. S. Anwer has authored 58 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Oncology, 15 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in M. S. Anwer's work include Drug Transport and Resistance Mechanisms (37 papers), Liver Disease Diagnosis and Treatment (13 papers) and Aldose Reductase and Taurine (8 papers). M. S. Anwer is often cited by papers focused on Drug Transport and Resistance Mechanisms (37 papers), Liver Disease Diagnosis and Treatment (13 papers) and Aldose Reductase and Taurine (8 papers). M. S. Anwer collaborates with scholars based in United States, Germany and Netherlands. M. S. Anwer's co-authors include D. Hegner, R. Kroker, Cynthia R. L. Webster, Larry R. Engelking, Piotr Zimniak, Ronald Gronwall, Kimberly A Cullen, J. McCool, Roger Lester and Lisa M. Clayton and has published in prestigious journals such as PLoS ONE, Hepatology and Biochemistry.

In The Last Decade

M. S. Anwer

57 papers receiving 978 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. S. Anwer United States 18 645 267 243 210 168 58 1.0k
Mizuho Une Japan 22 947 1.5× 542 2.0× 554 2.3× 215 1.0× 161 1.0× 86 1.5k
C D Schteingart United States 18 534 0.8× 187 0.7× 365 1.5× 108 0.5× 91 0.5× 31 824
Anh T. Truong United States 18 314 0.5× 310 1.2× 125 0.5× 296 1.4× 63 0.4× 31 1.1k
Brigitte O’Neill Switzerland 12 293 0.5× 193 0.7× 180 0.7× 78 0.4× 47 0.3× 12 680
Annie Zhao United States 12 617 1.0× 353 1.3× 380 1.6× 209 1.0× 160 1.0× 15 1.2k
Fernando A. Crocenzi Argentina 22 940 1.5× 294 1.1× 453 1.9× 267 1.3× 353 2.1× 48 1.4k
Janette Heegsma Netherlands 15 357 0.6× 253 0.9× 244 1.0× 282 1.3× 75 0.4× 28 792
Oscar A. Iseri United States 14 180 0.3× 295 1.1× 243 1.0× 377 1.8× 177 1.1× 22 1.2k
Ying Mu United States 14 425 0.7× 361 1.4× 312 1.3× 222 1.1× 406 2.4× 23 1.2k
Tohru SAEKI Japan 15 521 0.8× 248 0.9× 177 0.7× 77 0.4× 91 0.5× 31 763

Countries citing papers authored by M. S. Anwer

Since Specialization
Citations

This map shows the geographic impact of M. S. Anwer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. S. Anwer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. S. Anwer more than expected).

Fields of papers citing papers by M. S. Anwer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. S. Anwer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. S. Anwer. The network helps show where M. S. Anwer may publish in the future.

Co-authorship network of co-authors of M. S. Anwer

This figure shows the co-authorship network connecting the top 25 collaborators of M. S. Anwer. A scholar is included among the top collaborators of M. S. Anwer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. S. Anwer. M. S. Anwer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anwer, M. S.. (2024). Opportunities & Challenges of Artificial Intelligent-Powered Technology in Healthcare. Medical Research Archives. 12(3). 4 indexed citations
2.
Anwer, M. S., et al.. (2023). Relationship between IoT Service User Quality and Network QoS Factors. Journal for Research in Applied Sciences and Biotechnology. 2(2). 147–154. 1 indexed citations
3.
Mezzacappa, Catherine, Neal G. Ravindra, César Caraballo, et al.. (2020). Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure. PLoS ONE. 15(12). e0242928–e0242928. 9 indexed citations
4.
Anwer, M. S., et al.. (2019). Mulibrey Nanism Syndrome: A Case for Heart Transplantation. The Annals of Thoracic Surgery. 109(2). e115–e117. 2 indexed citations
5.
Anwer, M. S.. (2014). Intracellular Signaling by Bile Acids. Journal of Bio-Science. 20. 1–23. 26 indexed citations
6.
Hohenester, Simon, Ralf Wimmer, Ulrich Beuers, et al.. (2010). Phosphatidylinositol-3-kinase p110γ contributes to bile salt-induced apoptosis in primary rat hepatocytes and human hepatoma cells. Journal of Hepatology. 53(5). 918–926. 40 indexed citations
7.
Anwer, M. S.. (2004). Cellular regulation of hepatic bile acid transport in health and cholestasis. Hepatology. 39(3). 581–590. 89 indexed citations
8.
Cullen, Kimberly A, J. McCool, M. S. Anwer, & Cynthia R. L. Webster. (2004). Activation of cAMP-guanine exchange factor confers PKA-independent protection from hepatocyte apoptosis. American Journal of Physiology-Gastrointestinal and Liver Physiology. 287(2). G334–G343. 42 indexed citations
9.
Anwer, M. S. & Dennis J. Meyer. (1995). Bile Acids in the Diagnosis, Pathology, and Therapy of Hepatobiliary Disease. Veterinary Clinics of North America Small Animal Practice. 25(2). 503–517. 11 indexed citations
10.
Anwer, M. S.. (1993). Mechanism of ionomycin-induced intracellular alkalinization of rat hepatocytes. Hepatology. 18(2). 433–439. 12 indexed citations
11.
Anwer, M. S., et al.. (1991). Mechanism of inhibition of hepatic bile acid uptake by amiloride and 4,4′-diisothiocyano-2,2′-disulfonic stilbene (DIDS). Biochemical Pharmacology. 42. S135–S141. 9 indexed citations
12.
Zimniak, Piotr, Joanna M. Little, A Radominska, et al.. (1991). Taurine-conjugated bile acids act as calcium ionophores. Biochemistry. 30(35). 8598–8604. 35 indexed citations
13.
Albert, Klaus, James L. Sudmeier, M. S. Anwer, & William W. Bachovchin. (1989). Continuous‐flow 13C‐filtered 1H NMR spectroscopy of ethanol metabolism in rat liver perfusate. Magnetic Resonance in Medicine. 11(3). 309–315. 3 indexed citations
14.
Engelking, Larry R., M. S. Anwer, & A.F. Hofmann. (1989). Basal and bile salt-stimulated bile flow and biliary lipid excretion in ponies. American Journal of Veterinary Research. 50(4). 578–582. 4 indexed citations
15.
Anwer, M. S., et al.. (1988). Mechanism of hepatic bile acid uptake studies using dids. Hepatology. 8(5). 1259. 4 indexed citations
16.
Montrose, Marshall H., Roger Lester, Piotr Zimniak, M. S. Anwer, & Heini Murer. (1988). Bile acids increase cellular free calcium in cultured kidney cells (LLC-PK1). Pflügers Archiv - European Journal of Physiology. 412(1-2). 164–171. 15 indexed citations
17.
Anwer, M. S.. (1985). Furosemide choleresis in isolated perfused rat liver: partial dependency on perfusate sodium and chloride.. Journal of Pharmacology and Experimental Therapeutics. 235(2). 313–318. 1 indexed citations
18.
Ogilvie, Gregory K., Larry R. Engelking, & M. S. Anwer. (1985). Effects of plasma sample storage on blood ammonia, bilirubin, and urea nitrogen concentrations: Cats and horses. American Journal of Veterinary Research. 46(12). 2619–2622. 7 indexed citations
19.
Anwer, M. S. & D. Hegner. (1983). Sodium and chloride dependency of dibucaine- and procaine-induced choleresis in isolated perfused rat livers.. Journal of Pharmacology and Experimental Therapeutics. 225(2). 284–290. 3 indexed citations
20.
Gronwall, Ronald, et al.. (1975). Bile Secretion in Ponies with Biliary Fistulas. American Journal of Veterinary Research. 36(5). 653–654. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026